Levosimendan in acute pulmonary embolism

Anaesth Intensive Care. 2007 Oct;35(5):771-2. doi: 10.1177/0310057X0703500518.

Abstract

Levosimendan has been used successfully in the treatment of ischaemic cardiac failure and myocardial stunning. There is growing evidence from both human and animal experiments that levosimendan has particularly favourable effects on the right ventricle. We describe a case of life-threatening pulmonary embolus supported by the use of levosimendan.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Aged
  • Cardiotonic Agents / therapeutic use*
  • Humans
  • Hydrazones / therapeutic use*
  • Male
  • Pulmonary Artery
  • Pulmonary Embolism / drug therapy*
  • Pyridazines / therapeutic use*
  • Simendan

Substances

  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Simendan